What does Fairchem Organic do?

Fairchem Organics Ltd is a small-cap company in the specialty chemicals sector, focusing on oleo chemicals and nutraceuticals. As of March 2025, it reported net sales of 121 Cr and a net profit of 1 Cr, with a market cap of Rs 1,225 Cr.

Overview:<BR>Fairchem Organics Ltd is a small-cap company operating in the specialty chemicals industry, primarily focused on the manufacturing of specialty chemicals such as oleo chemicals and intermediate nutraceuticals.<BR><BR>History:<BR>Fairchem Organics Ltd was incorporated on March 27, 2019. The business was previously run under the name Fairchem Speciality Limited until August 12, 2020, after which it adopted its current name. The latest quarterly results report net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 121 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 1 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 1,225 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 55.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.81% <BR>Debt-Equity: 0.20 <BR>Return on Equity: 7.27% <BR>Price to Book: 4.00 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

When is the next results date for Fairchem Organic?

No Upcoming Board Meetings

Has Fairchem Organic declared dividend?

Yes, Fairchem Organics Ltd has declared a 75% dividend, amounting to ₹7.5 per share, with an ex-date of July 29, 2024. Despite this, the company's total returns over various periods have been negative, indicating challenging performance.

Fairchem Organics Ltd has declared a 75% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 75%<BR>- Amount per share: 7.5<BR>- Ex-date: Jul-29-2024<BR><BR>Dividend Yield: 0.81%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 9.97%, with no dividend return, resulting in a total return of 9.97%.<BR><BR>Over the past year, the price return was -25.63%, with a dividend return of 0.57%, leading to a total return of -25.06%.<BR><BR>For the 2-year period, the price return was -26.92%, the dividend return was 1.15%, and the total return was -25.77%.<BR><BR>In the 3-year period, the price return was -29.95%, with a dividend return of 2.03%, resulting in a total return of -27.92%.<BR><BR>Over the last 4 years, the price return was -0.2%, the dividend return was 1.87%, leading to a total return of 1.67%.<BR><BR>In the 5-year period, there was no price return and no dividend return, resulting in a total return of 0.0%.<BR><BR>Overall, while Fairchem Organics has declared a dividend, the total returns over various periods indicate a challenging performance, particularly in the longer terms, with significant negative price returns. The dividend yield remains modest, suggesting limited income relative to the investment risk.

Who are the peers of the Fairchem Organic?

Fairchem Organic's peers include Pidilite Industries, SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Indo Amines, Jayant Agro Org., Nitta Gelatin, Chemcon Special, and Sudarshan Pharma. Fairchem Organic has average management risk and below-average growth, with a 1-year return of -24.83%, the lowest among its peers.

Peers: The peers of Fairchem Organic are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Indo Amines, Jayant Agro Org., Nitta Gelatin, Chemcon Special, and Sudarshan Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Pidilite Inds., SRF, and Deepak Nitrite, while Average management risk is found at Gujarat Fluoroch, Himadri Special, Fairchem Organic, Indo Amines, Jayant Agro Org., Nitta Gelatin, Chemcon Special, and Sudarshan Pharma. Good growth is noted at Himadri Special, Indo Amines, and Jayant Agro Org., while Average growth is seen at Pidilite Inds., SRF, Nitta Gelatin, and the rest. Below Average growth is present at Gujarat Fluoroch, Deepak Nitrite, Fairchem Organic, Chemcon Special, and Sudarshan Pharma. Excellent capital structure is noted at Pidilite Inds., SRF, Deepak Nitrite, Fairchem Organic, Nitta Gelatin, and Chemcon Special, while Good capital structure is found at Gujarat Fluoroch, Himadri Special, and Jayant Agro Org., and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sudarshan Pharma at 355.66%, while Fairchem Organic has the lowest at -24.83%. Fairchem Organic's return is significantly lower than all its peers. Additionally, the peers with negative six-month returns include Deepak Nitrite, Himadri Special, Chemcon Special, and Sudarshan Pharma.

Who are in the management team of Fairchem Organic?

As of March 2023, the management team of Fairchem Organic includes Nahoosh J Jariwala (Chairman & Managing Director), Venkatraman Srinivasan, Darius Dinshaw Pandole, Sonal Ambani, and Sudhin Choksey (all Independent Directors), Sumit Maheshwari (Nominee), and Rajen Niranjanbhai Jhaveri (Company Secretary & Compliance Officer). The team reflects a diverse leadership structure.

As of March 2023, the management team of Fairchem Organic includes the following individuals:<BR><BR>1. Nahoosh J Jariwala - Chairman & Managing Director<BR>2. Venkatraman Srinivasan - Independent Director<BR>3. Darius Dinshaw Pandole - Independent Director<BR>4. Sonal Ambani - Independent Director<BR>5. Sumit Maheshwari - Nominee<BR>6. Rajen Niranjanbhai Jhaveri - Company Secretary & Compliance Officer<BR>7. Sudhin Choksey - Independent Director<BR><BR>As of March 2023, the management team consists of a mix of directors and officers, including independent directors and a compliance officer, reflecting a diverse leadership structure.

Who are the top shareholders of the Fairchem Organic?

The top shareholders of Fairchem Organic include Fih Mauritius Investments Ltd. with 52.83%, 23 Foreign Institutional Investors holding 6.31%, and the 360 One Special Opportunities Fund - Series 7 with 3.61%. Individual investors collectively own 18.37% of the company.

The top shareholders of Fairchem Organic include the promoters, who hold a majority stake in the company. The promoter with the highest holding is Fih Mauritius Investments Ltd., which owns 52.83% of the shares. Additionally, there are 23 Foreign Institutional Investors (FIIs) holding a combined 6.31% of the shares. The highest public shareholder is the 360 One Special Opportunities Fund - Series 7, with a holding of 3.61%. Individual investors collectively own 18.37% of the company.

How big is Fairchem Organic?

As of 24th July, Fairchem Organics Ltd has a market capitalization of 1,221.00 Cr, with recent Net Sales of 537.90 Cr and a Net Profit of 21.97 Cr. The company has Shareholder's Funds of 302.03 Cr and Total Assets of 401.83 Cr.

As of 24th July, Fairchem Organics Ltd has a market capitalization of 1,221.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Fairchem reported Net Sales of 537.90 Cr and a Net Profit of 21.97 Cr.<BR><BR>For the reporting period of March 2025, the company has Shareholder's Funds amounting to 302.03 Cr and Total Assets of 401.83 Cr.

Is Fairchem Organic technically bullish or bearish?

As of August 26, 2025, Fairchem Organic's technical trend has shifted to a bearish stance, supported by bearish MACD, moving averages, and Bollinger Bands, despite mixed signals from the KST and Dow Theory.

As of 26 August 2025, the technical trend for Fairchem Organic has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm a bearish outlook. Bollinger Bands are also indicating a bearish trend on both weekly and monthly time frames. The KST shows a mixed signal with weekly bullishness but monthly bearishness, while the Dow Theory reflects mildly bearish conditions on the weekly and mildly bullish on the monthly. Overall, the combination of these indicators suggests a bearish sentiment in the market for Fairchem Organic.

Are Fairchem Organic latest results good or bad?

Fairchem Organics' latest results are concerning, with a 20.54% year-on-year revenue decline and a 91.54% drop in net profit, indicating significant financial and operational challenges. The company faces severe margin compression, raising questions about its future viability.

Fairchem Organics' latest results indicate a challenging situation for the company. In Q2 FY26, the company reported a significant revenue decline of 20.54% year-on-year, bringing net sales down to ₹131.06 crores. This decline reflects ongoing operational challenges and weakening demand in the specialty chemicals sector.<BR><BR>The net profit also saw a drastic drop, plummeting by 91.54% year-on-year to just ₹1.17 crores, which translates to a very low profit after tax (PAT) margin of 0.89%. Furthermore, the operating margin collapsed to 3.98%, marking the lowest level in the company's recent history and a substantial decrease from 13.21% in the same quarter last year.<BR><BR>While there was a slight sequential improvement in revenue and net profit compared to the previous quarter, the overall performance remains concerning. The company faces severe margin compression and deteriorating profitability metrics, raising questions about its operational viability moving forward.<BR><BR>In summary, the latest results for Fairchem Organics can be characterized as bad, highlighting significant financial and operational difficulties that need to be addressed for any potential recovery.

Is Fairchem Organic overvalued or undervalued?

As of November 10, 2025, Fairchem Organic is considered undervalued with a valuation grade of very attractive, highlighted by a PE ratio of 152.68 and a year-to-date return of -41.54%, especially when compared to its peers like Solar Industries and Gujarat Fluorochemicals, which are viewed as very expensive.

As of 10 November 2025, Fairchem Organic's valuation grade has moved from fair to very attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 152.68, an EV to EBITDA of 67.16, and a Price to Book Value of 0.31, which highlight its potential for growth despite high valuation metrics.<BR><BR>In comparison to its peers, Fairchem Organic stands out with its very attractive valuation, while competitors like Solar Industries and Gujarat Fluorochemicals are deemed very expensive with PE ratios of 96.11 and 62.86, respectively. The company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -41.54% compared to the Sensex's 6.91%, further reinforcing the notion that Fairchem Organic may be undervalued in the current market environment.

How has been the historical performance of Fairchem Organic?

Fairchem Organic has experienced a declining trend in net sales, operating profit, and profitability metrics from Mar'23 to Mar'25, while total assets and liabilities increased. Cash flow from operating activities turned negative in Mar'25, indicating volatility in financial performance.

Answer:<BR>The historical performance of Fairchem Organic shows a fluctuating trend in key financial metrics over the past six years.<BR><BR>Breakdown:<BR>Fairchem Organic's net sales have decreased from 646.94 Cr in Mar'23 to 537.90 Cr in Mar'25, reflecting a downward trend. Total operating income also followed this decline, dropping from 648.04 Cr in Mar'23 to 537.90 Cr in Mar'25. The company's total expenditure, excluding depreciation, decreased from 575.71 Cr in Mar'23 to 495.12 Cr in Mar'25, indicating a reduction in costs. Operating profit (PBDIT) fell significantly from 73.01 Cr in Mar'23 to 44.12 Cr in Mar'25, while profit before tax also decreased from 58.59 Cr to 29.92 Cr in the same period. Consequently, profit after tax dropped from 43.50 Cr in Mar'23 to 21.97 Cr in Mar'25. The earnings per share (EPS) reflected this decline, falling from 33.41 in Mar'23 to 16.87 in Mar'25. On the balance sheet, total assets increased from 342.41 Cr in Mar'23 to 401.83 Cr in Mar'25, driven by a rise in current assets, particularly inventories and sundry debtors. Total liabilities also rose from 342.41 Cr to 401.83 Cr, primarily due to an increase in short-term borrowings. The cash flow from operating activities turned negative in Mar'25 at -16.00 Cr, contrasting with positive cash flows in previous years, while cash flow from financing activities showed a significant inflow of 42.00 Cr in Mar'25. Overall, Fairchem Organic's financial performance has shown volatility, with notable declines in profitability and cash flow, despite an increase in total assets and liabilities.

Should I buy, sell or hold Fairchem Organics Ltd?

Which are the latest news on Fairchem Organic?

Why is Fairchem Organics Ltd falling/rising?

As of 28-Dec, Fairchem Organics Ltd's stock price is rising to 699.40, reflecting a 0.35% increase. This short-term gain is driven by recent outperformance against the Sensex and increased investor participation, despite a significant year-to-date decline and ongoing long-term challenges.

As of 28-Dec, Fairchem Organics Ltd's stock price is rising, currently at 699.40, with a change of 2.45 (0.35%) upward. This increase can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 2.25% compared to the Sensex's 0.13%. Additionally, in the past month, the stock has shown a significant increase of 8.23%, while the Sensex has declined by 0.66%. <BR><BR>Today's performance indicates that the stock has outperformed its sector by 0.71%, and there has been a notable rise in investor participation, with delivery volume increasing by 67.14% against the 5-day average. The stock is also trading higher than its 5-day and 20-day moving averages, which may contribute to positive investor sentiment.<BR><BR>Despite these positive indicators, it is important to note that the stock has faced challenges over the longer term, with a year-to-date decline of 42.37% and a 1-year return of -41.67%. The company has reported negative results for the last five consecutive quarters, and its profits have fallen significantly by 85.6%. However, the current rise in stock price appears to be driven by short-term performance metrics and increased trading activity rather than a reversal of the company's longer-term struggles.